Drug safety during pregnancy and in infants: Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance

Annals of the New York Academy of Sciences

Volumn 918, Issue , 2000, Pages 222-235

  Lindegren, M L ^a   Rhodes, P ^a   Gordon, L ^a   Fleming, P ^a   Bulterys, M ^a   Burchett, S K ^a   Culnane, M ^a   Cunningham Schrader, B ^a   Dominguez, K ^a   Dunkle, L ^a   Draper, L ^a   Fowler, M G ^a   Hanson, C ^a   Kpamegan, E ^a   Martin Carpenter, L ^a   McIntosh, K ^a   McNamara, J ^a   McSherry, G ^a   Mitchell, W G ^a   Mofenson, L M ^a   Oleske, J M ^a   Shapiro, D E ^a   Smith, M E ^a   Styrt, B ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOPSY; CARCINOGENICITY; CHILD; CONFERENCE PAPER; COUNSELING; DEATH CERTIFICATE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRICS; PERINATAL MORBIDITY; POPULATION RESEARCH; PREGNANCY; PRENATAL EXPOSURE; VIRUS TRANSMISSION;

EID: 0033637597     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05492.x     Document Type: Conference Paper

References (33)

1. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
2. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
3. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus
4. US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women
5. Trends in perinatal transmission of HIV/AIDS in the United States
6. Intrapartum and neonatal single-dose Nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala Uganda: HIVNET012 randomized trial
7. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial
8. Short course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomized trial
9. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States
10. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
11. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
12. Lack of tumors in infants with perinatal HIV type 1 exposure and fetal/neonatal exposure to zidovudine
13. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
14. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine induced myopathy
15. Near-fatal metabolic acidosis, liver failure, and mitochondrial DNA depletion in HIV-infected children treated with combination antiretroviral therapy
16. Mitochondrial myopathy caused by long-term zidovudine therapy
17. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
18. Mitochondrial toxicity of perinatally adminstered zidovudine
19. Success in implementing PHS guidelines to reduce perinatal transmission of HIV-1993, 1995, and 1996
20. CDC Guidelines for National Human Immunodeficiency Virus Case Surveillance, including monitoring of human Immunodeficiency virus infection and acquired immunodeficiency syndrome
21. Review of deaths among a cohort of New York State infants exposed in the perinatal period to HIV and antiretroviral drugs
22. Review of neurological adverse events in relation to mitochondrial dysfunction in the prevention of mother to child transmission of HIV: Petra Study
23. Surveillance of pediatric HIV infection
24. Projection of AIDS and HIV incidence among children born infected with HIV
25. Prevalence and incidence of vertically acquired HIV infection in the United States
26. HIV nucleoside analogues: New adverse effects on mitochondria?
27. Childhood encephalopathies and myopathies: A prospective study in a defined population to assess the frequency of mitochondrial disorders